T. Hamamoto et W. Kisiel, FULL-LENGTH HUMAN TISSUE FACTOR PATHWAY INHIBITOR INHIBITS HUMAN ACTIVATED PROTEIN-C IN THE PRESENCE OF HEPARIN, Thrombosis research, 80(4), 1995, pp. 291-297
Previous studies have demonstrated that tissue factor pathway inhibito
r (TFPI) purified from a hepatoma cell line failed to inhibit human ac
tivated protein C (APC) or human thrombin. In the present study, we ha
ve examined the ability of full-length TFPI and a truncated form of TF
PI lacking the third Kunitz-type domain and C-terminal tail (TFPI1-161
) to inhibit the amidolytic activity of human APC in the presence and
absence of heparin. TFPI readily inhibited APC amidolytic activity onl
y in the presence of heparin, whereas TFPI1-161 failed to inhibit APC
amidolytic activity in the presence or absence of heparin. Optimal inh
ibition of APC by TFPI was observed at 1 U/ml heparin. The results of
competition studies between factor Xa and APC for inhibition by TFPI i
n the presence of heparin suggested that the second Kunitz-type domain
in TFPI was responsible for the inhibition of APC.